Live Breaking News & Updates on Surrounding Meetings

Stay updated with breaking news from Surrounding meetings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Future Outlooks in the Treatment of Advanced RCC

Experts close the discussion by sharing insights on the future in advanced RCC, emphasizing the development of emerging agents and combination regimens for the treatment landscape. ....

Surrounding Meetings , Kidney Cancer , Renal Cell Carcinoma , Advanced Rcc , Advanced Renal Cell Carcinoma , Rcc Treatment , Kidney Cancer Treatment , Renal Cell Carcinoma Treatment , Kidney Cancer Treatment Landscape , Treatment Landscape , Future Outlook ,

Impact of Treatment Selection and Real-World Outcomes in Advanced RCC

Brian Rini, MD, discusses the impact of real-world outcomes on treatment selection, highlighting frontline combination axitinib plus pembrolizumab in advanced RCC. ....

Brian Rini , Surrounding Meetings , Treatment Selection , Real World Outcomes , Kidney Cancer , Renal Cell Carcinoma , Advanced Rcc , Advanced Renal Cell Carcinoma , Advanced Kidney Cancer , Kidney Cancer Treatment , Rcc Treatment , Renal Cell Carcinoma Treatment ,

Tackling Toxicity Management in Combination Regimens for Advanced RCC

A comprehensive discussion on toxicity management and patient tolerability for combination regimens in the setting of advanced RCC. ....

Surrounding Meetings , Toxicity Management , Combination Regimens , Kidney Cancer , Renal Cell Carcinoma , Advanced Rcc , Advanced Renal Cell Carcinoma , Safety Profile , Rcc Treatment , Kidney Cancer Treatment , Renal Cell Carcinoma Treatment ,

CLEAR Trial: Lenvatinib plus Pembrolizumab in Advanced RCC

Experts highlight key clinical updates from the CLEAR trial presented at the 2023 IKCS: North America congress, assessing lenvatinib plus pembrolizumab in patients with advanced RCC. ....

United States , Surrounding Meetings , North America , Renal Cell Carcinoma , Advanced Renal Cell Carcinoma , Advanced Rcc , Renal Cell Carcinoma Treatments , Rcc Treatments , Clear Trial , Clear Study , Advanced Rcc Treatment , Advanced Renal Cell Carcinoma Treatment ,

The Evolution of Advanced Renal Cell Carcinoma

Brian Rini, MD, and Hans Hammers, MD, PhD, discuss the evolution of management for advanced renal cell carcinoma (RCC), noting the role of biomarkers and its use in practice. ....

Brian Rini , Surrounding Meetings , Advanced Renal Cell , Hans Hammers , Renal Cell Carcinoma , Advanced Renal Cell Carcinoma , Advanced Rcc , Clear Cell Renal Carcinoma , Clear Cell Rcc , Advanced Kidney Cancer , Kidney Cancer , Mutational Burden , Renal Cell Carcinoma Treatments , Rcc Treatments ,